High-Level Overview
Nawah Scientific is a deep-tech life sciences company founded in 2015 that operates MENA and Africa's first cloud lab, providing remote analytical and R&D services via an online platform.[1][5] Researchers and companies submit experiment requests and samples digitally; Nawah's scientists perform advanced testing across life sciences, food and agriculture, pharmaceuticals, and certified reference materials (CRM), delivering results online to clients in over 30 countries.[1][5] It serves industries needing product development, quality control, and compliance testing, solving the problem of limited access to expensive lab infrastructure by enabling remote, on-demand high-precision analysis—having processed over 1 million samples with 160 researchers.[1][5] The company recently raised $23 million in a Series A round (mix of equity and debt) led by Life Ventures Holding, with participation from Den Ventures, Empire M, AfricInvest, and others, fueling 10-year anniversary growth including doubled lab capacity in Egypt and Saudi Arabia, a 10,000-sqm global R&D center in Rwanda, and expansion into North Africa and Europe.[1][4][6] Prior funding totaled around $3.15 million.[2][3]
Origin Story
Nawah Scientific was founded in 2015 in Cairo, Egypt, by Omar Shokry Saqr, who serves as CEO, addressing the gap in accessible advanced research equipment for natural and medical sciences in the region.[1][5][7] The idea emerged from recognizing that academics and industries—like pharmaceuticals, agriculture, chemicals, and oil—lacked affordable, on-demand analytical services, leading to the cloud lab model where users request experiments online, submit samples (with pickup in Egypt), and receive digital results.[1][2][5] Early traction built over years: by around 2019, it had analyzed over 30,000 samples from 9 countries; pivotal moments include US FDA accreditation for food analysis in 2023 (first for an African entity), ISO 17034 accreditation for CRM production, and the landmark $23 million Series A in late 2025 marking a decade of operation.[1][3][5] These milestones, including partnerships like the Zewail City-led CRM Alliance winning a presidential initiative, propelled Nawah from a local hub to a regional leader trusted by 6,000+ clients worldwide.[5]
Core Differentiators
Nawah stands out in the life sciences testing space through these key strengths:
- Cloud Lab Model: Fully online platform for remote experiment requests, sample submission, analysis, and results delivery, eliminating the need for physical labs and enabling global access—unique as MENA/Africa's first.[1][5][6]
- Multi-Sector Expertise: Four specialized units—Life Science Research (core testing platform), Food & Agriculture (certified safety/quality for exporters), Pharma (R&D, formulation, stability studies), and CRM (one of few global producers of standards for lab calibration and validation).[1][5]
- Accreditations and Scale: US FDA-accredited for food analysis (first in Africa), ISO 17034 for CRM, with 1M+ samples tested, 160 researchers, and service to 30+ countries, positioning it for export-ready, compliant results.[1][3][5]
- Operational Efficiency: Sample pickup anywhere in Egypt, rapid turnaround, and expansion plans like Rwanda R&D hub enhance speed and geographic reach over traditional CROs.[1][5]
Role in the Broader Tech Landscape
Nawah rides the deep-tech wave in African and MENA life sciences, capitalizing on rising demand for localized R&D amid global supply chain shifts and continent-specific needs like food security, pharma localization, and agrotech.[1][3] Timing is ideal post-COVID, as remote/cloud lab models surged for resilient testing, while Africa's biotech boom—fueled by investments and initiatives like presidential alliances—creates tailwinds; Nawah's FDA/ISO creds reduce reliance on overseas labs, saving African firms time and costs.[1][3][5] It influences the ecosystem by pioneering CRM production (scarce regionally), enabling startups/universities in underserved areas, and driving exports—highlighted by Egypt's GAFI as a model for research-to-value creation—while expansions into Rwanda, North Africa, and Europe amplify Africa's role in global standards and deep-tech.[1][4]
Quick Take & Future Outlook
Nawah's $23 million Series A positions it for explosive scale, with the Rwanda R&D hub and lab doublings unlocking capacity for 2-3x growth in high-margin services like CRM and pharma R&D.[1] Trends like AI-driven analysis, pan-African trade blocs, and ESG-focused ag/food testing will shape its path, potentially capturing more of the $10B+ global CRO market underserved in emerging regions. Its influence may evolve from regional pioneer to global player, exporting standards and tech—echoing its founding vision of democratizing science, now supercharged for a decade-ahead dominance in cloud-enabled life sciences.[1][5]